Theranos raised more than $700 million from investors while making false or exaggerated statements about its technology, business and financial performance.

Format Web Page

Location PART 2 - FOUR HIDDEN CHIMNEYS CHAPTER 9: ARE UNICORNS REALLY WHITE? Valuation Gamification

"Theranos raised more than $700 million from investors while making false or exaggerated statements about its technology, business and financial performance."

The SEC charged Theranos and its executives over a years-long investor fraud involving false and exaggerated claims about its blood-testing technology, business and finances.

View Source

Source title Theranos, CEO Holmes, and Former President Balwani Charged With Massive Fraud

Source authors U.S. Securities and Exchange Commission

Source year 2018

Confidence high

Importance high